Detailed information for compound 282582

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 334.415 | Formula: C20H22N4O
  • H donors: 0 H acceptors: 0 LogP: 4.38 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: CN(/C=N/c1ccc(cc1)c1cc2c(o1)ccc(c2)/N=C/N(C)C)C
  • InChi: 1S/C20H22N4O/c1-23(2)13-21-17-7-5-15(6-8-17)20-12-16-11-18(22-14-24(3)4)9-10-19(16)25-20/h5-14H,1-4H3/b21-13+,22-14+
  • InChiKey: SYJJISZNVGQPIP-JFMUQQRKSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus glutamate receptor ionotrophic AMPA 3 0.0034 0.8263 0.7417
Echinococcus multilocularis nmda type glutamate receptor 0.0037 1 1
Loa Loa (eye worm) cytochrome P450 family protein 0.0027 0.5066 0.8879
Trypanosoma cruzi cytochrome P450, putative 0.0016 0 0.5
Brugia malayi Glutamate receptor 1 precursor 0.0028 0.5705 1
Echinococcus multilocularis glutamate (NMDA) receptor subunit 0.0028 0.5705 0.3615
Echinococcus granulosus glutamate receptor 2 0.0034 0.8263 0.7417
Leishmania major cytochrome p450-like protein 0.0016 0 0.5
Trypanosoma cruzi cytochrome P450, putative 0.0016 0 0.5
Echinococcus multilocularis Glutamate receptor, ionotropic kainate 2 0.0034 0.8263 0.7417
Chlamydia trachomatis arginine ABC transporter substrate-binding protein ArtJ 0.0027 0.5011 0.5
Echinococcus granulosus Glutamate receptor ionotropic kainate 2 0.0034 0.8263 0.7417
Loa Loa (eye worm) glutamate receptor 1 0.0028 0.5705 1
Schistosoma mansoni glutamate receptor NMDA 0.0034 0.8263 1
Echinococcus multilocularis glutamate receptor, ionotrophic, AMPA 3 0.0034 0.8263 0.7417
Echinococcus multilocularis Glutamate receptor, ionotropic kainate 3 0.0037 1 1
Echinococcus multilocularis Glutamate receptor, ionotropic kainate 2 0.0034 0.8263 0.7417
Brugia malayi Cytochrome P450 family protein 0.0027 0.5066 0.8879
Treponema pallidum amino acid ABC transporter, periplasmic binding protein (hisJ) 0.0027 0.5011 0.5
Mycobacterium tuberculosis Probable glutamine-binding lipoprotein GlnH (GLNBP) 0.0027 0.5011 0.5
Trypanosoma brucei cytochrome P450, putative 0.0016 0 0.5
Echinococcus multilocularis Glutamate receptor, ionotropic kainate 2 0.0034 0.8263 0.7417
Echinococcus granulosus Glutamate receptor ionotropic kainate 2 0.0034 0.8263 0.7417
Echinococcus multilocularis glutamate receptor 2 0.0028 0.5705 0.3615
Loa Loa (eye worm) glutamate receptor 2 0.0028 0.5705 1
Brugia malayi Glutamate receptor 2 precursor 0.0028 0.5705 1
Treponema pallidum amino acid ABC transporter, periplasmic binding protein 0.0027 0.5011 0.5
Mycobacterium ulcerans glutamine-binding lipoprotein GlnH 0.0027 0.5011 1
Echinococcus granulosus Glutamate receptor ionotropic kainate 2 0.0034 0.8263 0.7417
Chlamydia trachomatis glutamine binding protein 0.0027 0.5011 0.5
Echinococcus granulosus glutamate NMDA receptor subunit 0.0028 0.5705 0.3615
Echinococcus multilocularis glutamate receptor 2 0.0034 0.8263 0.7417

Activities

Activity type Activity value Assay description Source Reference
ID50 (binding) = 40 ug ml-1 Inhibitory dose against oncornaviral DNA polymerase activity of moloney murine leukemia virus ChEMBL. 6157024
ID50 (binding) = 40 ug ml-1 Inhibitory dose against oncornaviral DNA polymerase activity of moloney murine leukemia virus ChEMBL. 6157024

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.